Filling a gap in the literature, this all-encompassing reference explores the epidemiology, mechanisms, and pathophysiology of atrial fibrillation and compiles the latest diagnostic and treatment practices for patient care. The book summarizes the most recent advances in symptom relief, drug development, device management, and long-term control of heart rhythm abnormalities and reviews the latest studies on the prevention of stroke and other thromboembolic events in patients with valvular and nonvalvular atrial fibrillation. Finally, it offers new strategies to improve the therapy and...

New Arrhythmia Technologies provides a complete discussion of recent, emerging, and future arrhythmia technologies. This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase. The elite panel of authors have explored fresh information on: advances in antiarrhythmic pharmacologis therapy advances in monitoring, risk assessment, and noninvasive mapping advances in pacing therapy advances in implantable defibrillators advances in catheter and surgical ablation advances in antiarrhythmic biological therapy vision for the...

Cardiac electrophysiologists have many options for treating arrhythmias, including catheter ablation and implantable cardiac defibrillators.? Antiarrhythmic agents, which are pharmaceutical agents used to suppress fast rhythms of the heart (cardiac arrhythmias), represent another treatment option. This issue summarizes? the most current thinking on the role of pharmaceuticals in relation to other types of treatment, helping electrophysiologists to determine the best method for managing their patients.